Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.23 CAD -4.44% Market Closed
Market Cap: 88.5m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Covalon Technologies Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Common Shares Outstanding
CA$24.7m
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
10%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Common Shares Outstanding
CA$2.4m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Common Shares Outstanding
$46m
CAGR 3-Years
-22%
CAGR 5-Years
-10%
CAGR 10-Years
-3%
ESSA Pharma Inc
NASDAQ:EPIX
Common Shares Outstanding
$44.4m
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
49%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Common Shares Outstanding
$143.1m
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
16%
Spectral Medical Inc
TSX:EDT
Common Shares Outstanding
CA$282.8m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
5%
No Stocks Found

Covalon Technologies Ltd
Glance View

Market Cap
88.5m CAD
Industry
Biotechnology

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. The company is headquartered in Mississauga, Ontario. The company went IPO on 2004-09-03. The firm uses science and technology to help solve medical challenges associated with prevention, detection and management of areas such as infection, tissue repair and medical devices. Its products include Advanced Wound Care, Vascular Access, Perioperative Care and Urology. Advanced Wound Care is designed for the treatment of a range of wounds and offers CovaWound and ColActive brands. Vascular Access portfolio includes CovaView IV, a transparent film dressing that provides an effective barrier against external contaminants, including fluid, bacteria, and yeast. Perioperative care refers to the three Phases of surgery, including preoperative, intraoperative, and postoperative care and its brands include MediClear and SurgiClear.

COV Intrinsic Value
2.73 CAD
Overvaluation 15%
Intrinsic Value
Price

See Also

What is Covalon Technologies Ltd's Common Shares Outstanding?
Common Shares Outstanding
24.7m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Common Shares Outstanding amounts to 24.7m CAD.

What is Covalon Technologies Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
10%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Covalon Technologies Ltd have been -2% over the past three years , 2% over the past five years , and 10% over the past ten years .

Back to Top